Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.

You can find text and video tutorials here that explain how to use our system.

Microembed Pharmaceuticals IVS

CVR number: 38203312
Camilla Nielsens Vej 1, 2000 Frederiksberg
adam.bohr@sund.ku.dk
tel: 21740095

Credit rating

Company information

Official name
Microembed Pharmaceuticals IVS
Established
2016
Company form
Entrepreneurial limited company
Industry
  • Expand more icon21Manufacture of basic pharmaceutical products and pharmaceutical preparations

About the company

Microembed Pharmaceuticals IVS (CVR number: 38203312) is a company from FREDERIKSBERG. The company recorded a gross profit of -5.5 kDKK in 2018. The operating profit was -5.5 kDKK, while net earnings were -5.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -11.3 %, which can be considered poor and Return on Equity (ROE) was -38.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 48.5 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Microembed Pharmaceuticals IVS's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
20172018
Volume
Net sales
Gross profit251.83-5.46
EBIT27.13-5.46
Net earnings18.29-5.88
Shareholders equity total18.3912.51
Balance sheet total (assets)70.7025.80
Net debt-68.00-23.10
Profitability
EBIT-%
ROA38.4 %-11.3 %
ROE99.5 %-38.1 %
ROI128.6 %-30.1 %
Economic value added (EVA)20.97-2.84
Solvency
Equity ratio26.0 %48.5 %
Gearing14.7 %21.6 %
Relative net indebtedness %
Liquidity
Quick ratio1.41.9
Current ratio1.41.9
Cash and cash equivalents70.7025.80
Capital use efficiency
Trade debtors turnover (days)
Net working capital %
Credit risk
Credit ratingBB

Variable visualization

ROA:-11.3%
Rating: 9/100
-20%
0%
4%
11%
24%
60%
Equity ratio:48.5%
Rating: 39/100
-1%
21%
50%
81%
99%
100%

Companies in the same industry

Build time: 2024-07-12T11:31:30.432Z

Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.